Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
Ghelardi A, Marrai R, Bogani G, Sopracordevole F, Bay P, Tonetti A, Lombardi S, Bertacca G, Joura EA.
Vaccines (Basel). 2021 Jan 25;9(2):83. doi: 10.3390/vaccines9020083
The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM)
Lin KL, Chou SH, Loo ZX, Liu YY, Cheng JC, Long CY
Lasers Med Sci. 2022 Jun;37(4):2203-2208.
Treating Vaginal Relaxation Syndrome Using Erbium: Yttrium Aluminum Garnet Fractional Laser: A Retrospective Study
Setyaningrum T, Tjokroprawiro BA, Listiawan MY, Santoso B, Prakoeswa CRS
Gynecol Minim Invasive Ther. 2022 Feb 14;11(1):23-27.
Vaginal erbium laser for treatment of stress urinary incontinence: optimization of treatment regimen for a sustained long-term effect
Gaspar A, Koron N, Silva J, Brandi H.
Lasers Med Sci. 2022 Jun;37(4):2157-2164.
Changes in sexual function and vaginal topography using transperineal ultrasound after vaginal laser treatment for women with stress urinary incontinence
Long CY, Wu PC, Chen HS, Lin KL, Loo Z, Liu Y, Wu CH.
Sci Rep. 2022 Mar 2;12(1):3435.
Outcomes of ER:YAG LASER treatment of stress urinary incontinence in women
Neimark, A.I., Yakovleva, A.Y. & Lapii, G.A.,
Urologiia. 2018 May;(2):20-25. (Moscow, Russia: 1999)
Erbium:YAG laser treatment of female stress urinary incontinence: midterm data
Kuszka, A., Gamper, M., Walser, C. et al.
Int Urogynecol J 31, 1859–1866 (2020)
Effect of laser on pelvic floor strength and sexual satisfaction in women complaining of vaginal looseness: A randomized controlled trial
Ahmed, S.M. et al.
Fizjoterapia Polska, 19(2), pp.88–93.
Case report: Vulvodynia treated with Erbium:YAG laser
Erel TC.
Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:280-281
Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study)
Okui, N., Okui, M. & Vizintin, Z.
Climacteric (2020). The journal of the International Menopause Society, 23(sup1), pp.S14–S17.
Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists
N .Okui
World J Urol. (2019), 37(11):2459-2466. doi: 10.1007/s00345-019-02644-7
Rationale and design for fractional microablative CO 2 laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial
Flint, R. et al.
Climacteric. 2019 Jun;22(3):307-311. doi: 10.1080/13697137.2018.1559806